Form 40-F - Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]:
SEC Accession No. 0001410578-25-000588
Filing Date
2025-03-31
Accepted
2025-03-31 17:00:18
Documents
103
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 40-F crdl-20241231x40f.htm   iXBRL 40-F 216884
2 EX-99.1 crdl-20241231xex99d1.htm EX-99.1 799961
3 EX-99.2 crdl-20241231xex99d2.htm   iXBRL EX-99.2 1055331
4 EX-99.3 crdl-20241231xex99d3.htm EX-99.3 585827
5 EX-99.4 crdl-20241231xex99d4.htm EX-99.4 14328
6 EX-99.5 crdl-20241231xex99d5.htm EX-99.5 15636
7 EX-99.6 crdl-20241231xex99d6.htm EX-99.6 6714
8 EX-99.7 crdl-20241231xex99d7.htm EX-99.7 6744
9 EX-99.8 crdl-20241231xex99d8.htm EX-99.8 7354
10 GRAPHIC crdl-20241231x40f001.jpg GRAPHIC 12874
11 GRAPHIC crdl-20241231xex99d2001.jpg GRAPHIC 11561
12 GRAPHIC crdl-20241231xex99d2002.jpg GRAPHIC 3665
13 GRAPHIC crdl-20241231xex99d2004.jpg GRAPHIC 2730
14 GRAPHIC crdl-20241231xex99d3001.jpg GRAPHIC 18292
15 GRAPHIC crdl-20241231xex99d8001.jpg GRAPHIC 3071
16 GRAPHIC crdl-20241231xex99d8002.jpg GRAPHIC 2730
  Complete submission text file 0001410578-25-000588.txt   8715973

Data Files

Seq Description Document Type Size
17 EX-101.SCH crdl-20241231.xsd EX-101.SCH 74832
18 EX-101.CAL crdl-20241231_cal.xml EX-101.CAL 35789
19 EX-101.DEF crdl-20241231_def.xml EX-101.DEF 192320
20 EX-101.LAB crdl-20241231_lab.xml EX-101.LAB 463233
21 EX-101.PRE crdl-20241231_pre.xml EX-101.PRE 374792
106 EXTRACTED XBRL INSTANCE DOCUMENT crdl-20241231x40f_htm.xml XML 1462000
Mailing Address 602-2265 UPPER MIDDLE ROAD EAST OAKVILLE A6 L6H 0G5
Business Address 602-2265 UPPER MIDDLE ROAD EAST OAKVILLE A6 L6H 0G5 289-910-0850
Cardiol Therapeutics Inc. (Filer) CIK: 0001702123 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 40-F | Act: 34 | File No.: 001-40712 | Film No.: 25794627
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)